Telehealth Certification Institute

Call Now

Text Now

Call Now

Text Now

Overcoming Barriers and Improving Treatment Via Enhearten

Micah Goodman, the CEO of Enhearten, a mobile application tool that helps clients navigate the substance-use treatment process, talks with Ray Barrett from the Telehealth Certification Institute about how his company follows clients through their recovery journeys from start to finish. 

Enhearten is more than a business for Goodman, and he shares with Ray what inspired the company, and he emphasizes that “we exist to help you,” nodding to the altruistic roots that informed the vision for his company.

In this video interview, Goodman talks about his vision for the company, and how it can be a benefit to both patients and providers. For Goodman, Enhearten is more than a business; it’s meant to assist clients at any point in their recovery.

Enhearten offers clients a free mobile app, and clinicians can access a suite of patient management tools, which include HIPAA-compliant messaging, remote patient monitoring, and treatment planning features. Goodman also curates his addiction provider directory on a regular basis to ensure users get accurate results. 

For clients who want more autonomy and control in their treatment, the app includes a provider search tool, a programmable calendar with appointment reminders, medication alerts, and educational resources on useful addiction topics. Goodman hopes that his app gives clients a better understanding of their addiction and recovery by providing essential resources. 

At the end of the day, Goodman stresses that individuals who struggle with addiction should not be working overtime against systemic barriers. Goodman hopes that his technology will change how society views and treats addiction by prioritizing clients every step of the way.

If you’re interested in learning more, you can visit the Enhearten website or contact Micah directly at This email address is being protected from spambots. You need JavaScript enabled to view it..

By: Michael Tugendhat